RxDoctor Payments Data

Stacey Whalen

Family · Macon, GANPI 1700399805

Payments from drug & device makers

$5,290in general payments, 2019–2025

Across 251 payments — averaging $21.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$648
  • Amgen$635
  • Corium, LLC$472
  • AstraZeneca$257
  • Abbott$257
  • plus $2K from 29 others

What the payments were for

  • Food & beverage$5,290100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,290 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide40$49,865
OzempicSemaglutide27$25,378
JardianceEmpagliflozin21$18,211
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$15,760
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$5,931
Levemir FlexpenInsulin Detemir14$5,863
Levothyroxine Sodium56$693
Gabapentin32$579
Omeprazole46$451
Fluticasone Propionate23$427
Pregabalin14$424
Amlodipine Besylate57$389
Carvedilol23$381
Venlafaxine Hcl ErVenlafaxine Hcl26$379
Amitriptyline Hcl12$374

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$126$49,86540 claims
Novo NordiskOzempic$648$25,37827 claims
Boehringer IngelheimJardiance$39$18,21121 claims
GSKTrelegy Ellipta$34$15,76013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.

Other family in Macon

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →